Canonical Source · peer reviewed study

A clinical trial of amygdalin (Laetrile) in the treatment of human cancer

This page documents how this source is reused across Claim by Claim. A source can support, challenge, qualify or contextualize different claims; appearing here does not imply endorsement of every linked proposition.

Evidence context

How this source is used

Evidence roles describe what this source helps establish inside each Investigation. They are local to that use, not permanent labels attached to the publication itself.

Investigation

Can amygdalin or laetrile treat cancer?

Challenges

A 178-patient clinical study using amygdalin/laetrile as part of a metabolic-therapy program found no substantive benefit in cure, tumour stabilization, cancer symptoms or survival.

Subject families

Skin Empiric
Skin